Advertiser / Brand
Brown-Forman vs Heaps Normal
Structured technology and market comparison · 2026
Direct Feature Comparison
Brown-Forman · vs · Heaps NormalGlobal spirits brand owner and marketer.
Non-alcoholic craft beer brand selling D2C and wholesale.
Analyze all overlapping signals and tech stacks for Brown-Forman and Heaps Normal
Compare mutual enterprise clients, monetization models, live market signals, and partner networks directly in the interactive Knowledge Graph.
Comparison Analysis
What is the main difference between Brown-Forman and Heaps Normal?
When comparing Brown-Forman and Heaps Normal, both platforms operate within the Advertiser / Brand ecosystem. Brown-Forman is positioned as Global spirits brand owner and marketer, whereas Heaps Normal focuses on Non-alcoholic craft beer brand selling D2C and wholesale. Decision-makers evaluate both solutions when orchestrating their commercial monetization and technology stack.
What are the top alternatives to Brown-Forman and Heaps Normal?
When evaluating Brown-Forman and Heaps Normal, enterprise buyers also consider other platforms in Advertiser / Brand. You can discover the full competitive landscape and evaluate other alternatives by viewing their respective footprint profiles on Polaris7.
How do the corporate scale, structure, and headquarters of Brown-Forman and Heaps Normal compare?
Brown-Forman is headquartered in United States (founded in 1870) with 1,001–5,000 employees. Heaps Normal is based in Australia (founded in 2019) with 10–49 employees. Complete ownership, subsidiary trees, and corporate affiliations are documented across Polaris7.
Market Signals
Recent Market Signals & Activity: Brown-Forman vs Heaps Normal
Documented market movements, strategic partnerships, product releases, and regulatory developments mapped across Polaris7.
Brown-Forman
Recent Signals
- ·SEC APIfinancials
10-Q Financial Filing Analysis for Brown-Forman (2026-09-02)
For the first quarter of fiscal 2027 ended July 31, 2026, Brown-Forman Corporation reported net sales of $911 million, representing a 1% decline (1% organic decline) compared to the prior-year period. The top-line reduction was driven by unfavorable price/mix and the termination of the Korbel distribution relationship, partially offset by volumetric gains in Ready-to-Drink (RTD) offerings like New Mix. Gross profit contracted 1% to $549 million, though gross margin expanded 40 basis points to 60.2% due to lower input costs and portfolio mix adjustments. Operating income fell 3% to $252 million as operating expenses climbed 2% to $297 million, impacted by the absence of prior-year substitution drawback claims and higher SG&A costs. Net income rose 4% to $176 million ($0.38 per diluted share), boosted by a sharp reduction in non-operating postretirement expense. Management reaffirmed a cautious full-year fiscal 2027 outlook, anticipating flat organic net sales and a 3% to 5% decline in organic operating income.
- Net sales decreased 1% year-over-year to $911 million (1% organic decline), while gross margin improved by 40 basis points to 60.2%.
- Operating income declined 3% to $252 million, but net income rose 4% to $176 million ($0.38 diluted EPS) due to postretirement expense dropping from $19 million to $1 million.
- Full-year fiscal 2027 guidance projects organic net sales to be flat, organic operating income to contract by 3% to 5%, and capital expenditures between $60 million and $70 million.
- ·SEC APIfinancials
8-K Financial Filing Analysis for Brown-Forman (2026-09-21)
On September 21, 2026, Brown-Forman Corporation completed a public debt offering of $500 million aggregate principal amount of 5.375% Senior Notes due October 15, 2031. The underwriting agreement was executed on September 17, 2026, with a syndicate of major underwriters including Barclays Capital, BofA Securities, Citigroup, J.P. Morgan, and U.S. Bancorp Investments. The notes pay interest semi-annually on April 15 and October 15, commencing April 15, 2027. Net proceeds from the offering will be allocated towards general corporate purposes, which encompass dividend distributions, share repurchases, refinancing or repurchasing outstanding indebtedness (including commercial paper), working capital, capital expenditures, acquisitions, and pension obligations.
- Completed the issuance and sale of $500,000,000 aggregate principal amount of 5.375% Notes due October 15, 2031.
- Interest is payable semi-annually on April 15 and October 15 of each year, beginning April 15, 2027.
- Proceeds will support general corporate purposes including debt refinancing (commercial paper), stock buybacks, dividends, capex, and M&A.
Heaps Normal
Recent Signals
No recent market signals documented for Heaps Normal in the current tracking window.
Compare their exact ecosystem overlaps.
Explore all deep relationships in Polaris7. Discover exactly which mutual clients, integrated technologies, and overlapping partners Brown-Forman and Heaps Normal share across the market ecosystem.
Unlock full capability matrix, client overlaps & technology stacks
